digital health investment fund
The company will fund and develop companies that focus on eight key areas in healthcare and create AI/genAI technologies that help advance those areas.
The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.
Lynne Chou O'Keefe, founder and managing partner of Define Ventures, tells MobiHealthNews what characteristics of a company are essential to garner investment.
The fund will be zeroing in on sensing tech, data analytics, remote patient monitoring and population health.
Also: NeuroFlow's $20 million Series B, and the launch of two new health tech investment funds.
The new fund will follow in the footsteps of its predecessor, targeting technology investment opportunities that drive value-based healthcare.